California [US], June 5 (ANI): A new targeted therapy medicine can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening, according to an international trial co-led by UCLA. The discovery provides a potential new therapeutic option for those suffering from the…Read More
New drug delays progression of deadly brain cancer
